Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Marcu

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
The Journal of Experimental Medicine|December 24, 2019
Identification of HCMV-derived T cell epitopes in seropositive individuals through viral deletion modelsMaren Lübke, Stefanie Spalt, Daniel J Kowalewski, et al.
Nucleic Acids Research|November 14, 2023
PathBank 2.0-the pathway database for model organism metabolomicsDavid S Wishart, Ray Kruger, Aadhavya Sivakumaran, et al.
Journal for Immunotherapy of Cancer|October 2, 2021
Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumorsAna Marcu, Andreas Schlosser, Anne Keupp, et al.
Nucleic Acids Research|November 11, 2017
DrugBank 5.0: a major update to the DrugBank database for 2018David S Wishart, Yannick D Feunang, An C Guo, et al.
Acta Neuropathologica|March 21, 2018
The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapyMarian Christoph Neidert, Daniel Johannes Kowalewski, Manuela Silginer, et al.
Journal for Immunotherapy of Cancer|August 31, 2025
HLA Ligand Atlas DIA: extending the benign immunopeptidomics resource with increased sensitivity through data-independent acquisition mass spectrometryLeon Bichmann, Ana Marcu, Daniel Johannes Kowalewski, et al.
Blood|December 12, 2018
The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapyTatjana Bilich, Annika Nelde, Leon Bichmann, et al.
Nucleic Acids Research|November 16, 2017
HMDB 4.0: the human metabolome database for 2018David S Wishart, Yannick Djoumbou Feunang, Ana Marcu, et al.
Journal for Immunotherapy of Cancer|April 16, 2021
HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapyAna Marcu, Leon Bichmann, Leon Kuchenbecker, et al.
Oncoimmunology|December 3, 2021
Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survivalFiamma Berner, Rebekka Niederer, Jolien J Luimstra, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
The Journal of Experimental Medicine|December 24, 2019
Identification of HCMV-derived T cell epitopes in seropositive individuals through viral deletion modelsMaren Lübke, Stefanie Spalt, Daniel J Kowalewski, et al.
Nucleic Acids Research|November 14, 2023
PathBank 2.0-the pathway database for model organism metabolomicsDavid S Wishart, Ray Kruger, Aadhavya Sivakumaran, et al.
Journal for Immunotherapy of Cancer|October 2, 2021
Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumorsAna Marcu, Andreas Schlosser, Anne Keupp, et al.
Nucleic Acids Research|November 11, 2017
DrugBank 5.0: a major update to the DrugBank database for 2018David S Wishart, Yannick D Feunang, An C Guo, et al.
Acta Neuropathologica|March 21, 2018
The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapyMarian Christoph Neidert, Daniel Johannes Kowalewski, Manuela Silginer, et al.
Journal for Immunotherapy of Cancer|August 31, 2025
HLA Ligand Atlas DIA: extending the benign immunopeptidomics resource with increased sensitivity through data-independent acquisition mass spectrometryLeon Bichmann, Ana Marcu, Daniel Johannes Kowalewski, et al.
Blood|December 12, 2018
The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapyTatjana Bilich, Annika Nelde, Leon Bichmann, et al.
Nucleic Acids Research|November 16, 2017
HMDB 4.0: the human metabolome database for 2018David S Wishart, Yannick Djoumbou Feunang, Ana Marcu, et al.
Journal for Immunotherapy of Cancer|April 16, 2021
HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapyAna Marcu, Leon Bichmann, Leon Kuchenbecker, et al.
Oncoimmunology|December 3, 2021
Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survivalFiamma Berner, Rebekka Niederer, Jolien J Luimstra, et al.
Pageof 4